Neurotensin induces Fos and Zif268 expression in limbic nuclei of the rat brain

Neuroscience

Volumn 75, Issue 4, 1996, Pages 1141-1151

  Lambert, P D ^a   Ely, T D ^a   Gross, R E ^a   Kilts, C D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

amygdala; corticosterone; Fos; neurotensin; paraventricular nucleus of the hypothalamus; Zif268

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; NEUROTENSIN; NEUROTENSIN RECEPTOR ANTAGONIST;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; GENE EXPRESSION; IMMEDIATE EARLY GENE; IMMUNOHISTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC SYSTEM; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 0030298343     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00210-2     Document Type: Article

References (32)

1. 1. Abate C. and Curran T. (1990) Encounters with Fos and Jun on the road to AP-1. Semin. Cancer Biol. 1, 19-26.
2. 2. Andreae L. C. and Herbert J. (1993) Expression of c-fos in restricted areas of the basal forebrain and brainstem following single or combined intraventricular infusions of vasopressin and corticotropin-releasing factor. Neuroscience 53, 735-748.
3. 3. Beaulieu S., Di Paolo T., Cote J. and Barden N. (1987) Participation of the central amygdaloid nucleus in the response of adrenocorticotropin secretion to immobilization stress: opposing roles of the noradrenergic and dopaminergic systems. Neuroendocrinology 45, 37-46.
4. 4. Bissette G., Nemeroff C. B., Loosen P. T., Prange A. J. and Lipton M. A. (1976) Hypothermia and cold tolerance induced by the intracisternal administration of the hypothalamic peptide neurotensin. Nature 262, 607-609.
5. 5. Carraway R. and Leeman S. E. (1973) The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J. biol. Chem. 248, 6854-6861.
6. 6. Ceccatelli S., Villar M., Goldstein M. and Hokfelt T. (1989) Expression of c-Fos immunoreactivity in transmitter-characterised neurons after stress. Proc. natn. Acad. Sci. U.S.A. 86, 9569-9573.
7. 7. Christy B. and Nathans D. (1989) DNA binding site of the growth factor inducible protein Zif268. Proc. natn Acad. Sci. U.S.A. 86, 8737-8741.
8. 8. Cole A. J., Bhat R. V., Patt C., Worley P. F. and Baraban J. M. (1992) D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem 58, 1420-1426.
9. 9. Dragunow M., Yamada K., Bilkey D. K. and Lawlor P. (1992) Induction of immediate-early gene proteins in dentate granule cells and somatostatin interneurons after hippocampal seizures. Molec. Brain Res. 13, 119-126.
10. 10. Dubuc I., Costentin J., Terranova J. P., Barnouin M. C., Soubrie P., Le Fur G., Rostene W. and Kitabgi P. (1994) The nonpeptide neurotensin antagonist, SR48692, used as a tool to reveal putative neurotensin receptor subtypes. Br. J. Pharmac. 112, 352-354.
11. 11. Dunn J. D. and Whitener J. (1986) Plasma corticosterone responses to electrical stimulation of the amygdaloid complex: cytoarchitectural specificity. Neuroendocrinology 42, 211-217.
12. 12. Graybiel A. M., Moratalla R. and Robertson H. A. (1990) Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. natn Acad. Sci. U.S.A. 87, 6912-6916.
13. 13. Gudelsky G. A., Berry S. A. and Meltzer H. Y. (1989) Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat. Neuroendocrinology 49, 604-609.
14. 14. Hawkins M. F. (1986) Central nervous system neurotensin and feeding. Physiol. Behav. 36, 1-8.
15. 15. Hughes P. and Dragunow M. (1994) Activation of pirenzapine-sensitive muscarinic receptors induces a specific pattern of immediate early gene expression in rat brain neurons. Brain Res. 24, 166-178.
16. 16. Hughes P. and Dragunow M. (1995) Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmac. Rev. 47, 133-178.
17. 17. Kalivas P. W., Nemeroff C. B. and Prange A. J. (1982) Neuroanatomical sites of action of neurotensin. Ann. N.Y. Acad. Sci. 400, 307-316.
18. 18. Kamegai J., Minami S. and Wakabayashi I. (1993) Barrel rotation evoked by intracerebroventricular injection of somatostatin and arginine-vasopressin is accompanied by the induction of c-fos gene expression in the granular cells of rat cerebellum. Molec. Brain Res. 18, 115-120.
19. 19. Kitabgi P., Checler F., Mazella J. and Vincent J. P. (1985) Pharmacology and biochemistry of neurotensin receptors. Rev. clin. Basic Pharmac. 5, 397-486.
20. 20. Krahn D. D., Gosnell B. A., Levine A. S. and Morley J. E. (1988) Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res. 443, 63-69.
21. 21. Lambert P. D., Phillips P. J., Wilding J. P. H., Bloom S. R. and Herbert J. (1995) c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y. Brain Res. 670, 59-65.
22. 22. Leibowitz S. F., Sladek C., Spencer L. and Tempel D. (1988) Neuropeptide Y, epinephrine and norepinephrine in the paraventricular nucleus: stimulation of feeding and the release of corticosterone, vasopressin and glucose. Brain Res. Bull. 21, 905-912.
23. 23. Nemeroff C. B., Bissette G., Prange A. J. Jr, Loosen P. T., Barlow T. S. and Lipton M. A. (1977) Neurotensin: central nervous system effects of a hypothalamic peptide. Brain Res. 128, 485-496.
24. 24. Nemeroff C. B., Levant B., Myers B. and Bissette G. (1992) Neurotensin, antipsychotic drugs, and schizophrenia. Basic and clinical studies. Ann. N.Y. Acad. Sci. 668, 146-156.
25. 25. Nicot A., Berod A., Gully D., Rowe W., Quirion R., de Kloet R. and Rostene W. (1994) Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists. Neuroendocrinology 59, 572-578.
26. 26. Parkes D., Rivest S., Lee S., Rivier C. and Vale W. (1993) Corticotropin-releasing factor activates c-fos, NGFI-B, and corticotropin-releasing factor gene expression within the paraventricular nucleus of the rat hypothalamus. Molec. Endocr. 7, 1357-1367.
27. 27. Pinnock R. D. and Woodruff G. N. (1994) The non-peptide neurotensin receptor antagonist SR48692 is not a potent antagonist of neurotensin(8-13) responses of rat substantia nigra neurones in vitro. Neurosci. Lett. 172, 175-178.
28. 28. Rea M. A. (1989) Light increases Fos-related protein immunoreactivity in the rat suprachiasmatic nuclei. Brain Res. Bull. 23, 577-581.
29. 29. Rosahl T. W., Spillane D., Missler M., Herz J., Selig D. K., Wolff J. R., Hammer R. E., Malenka R. C. and Sudhof T. C. (1995) Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375, 488-493.
30. 30. Thiel G., Schoch S. and Petersohn D. (1994) Regulation of synapsin I gene expression by the zinc finger transcription factor M268/egr-1. J. biol. Chem. 269, 15294-15301.
31. 31. Uhl G. R., Kuhar M. J. and Snyder S. H. (1977) Neurotensin: immunohistochemical localization in the central nervous system. Proc. natn Acad. Sci. U.S.A. 4, 4059-4063.
32. 32. Van de Kar L. D., Piechowski R. A., Rittenhouse P. A. and Gray T. S. (1991) Amygdaloid lesions: differential effect on conditioned stress and immobilization-induced increases in corticosterone and renin secretion. Neuroendocrinology 54, 89-95.